Clinical Outcomes of Robotic Myomectomy

Last updated: January 5, 2024
Sponsor: Far Eastern Memorial Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Uterina Myoma

Desmoid Tumors

Uterine Fibroids

Treatment

Robotic myomectomy

Clinical Study ID

NCT06208891
112185-E
  • Ages > 20
  • Female

Study Summary

To identify the predictors of perioperative outcomes in women who receive robotic myomectomy

Eligibility Criteria

Inclusion

Inclusion criteria

  • >20 years old women

  • women who received robotic myomectomy

Study Design

Total Participants: 400
Treatment Group(s): 1
Primary Treatment: Robotic myomectomy
Phase:
Study Start date:
November 21, 2023
Estimated Completion Date:
December 31, 2024

Study Description

Uterine myoma is the most common gynecological tumor. Current surgical management was inclusive of conventional abdominal myomectomy, laparoscopy-assisted myomectomy, robotic-assisted myomectomy. The aim of this study was to identify the predictors of perioperative outcomes in women who receive robotic myomectomy

Connect with a study center

  • Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital

    Banqiao, New Taipei 22050
    Taiwan

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.